Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenues [Abstract]        
Net sales $ 1,046,257 $ 127,821 $ 1,672,888 $ 127,821
Grant revenue 28,433 67,456 153,606 67,456
Total revenue 1,074,690 195,277 1,826,494 195,277
Cost of goods sold 270,498 105,438 463,718 105,438
Gross profit 804,192 89,839 1,362,776 89,839
Operating expenses:        
Research and development 5,112,098 4,376,833 10,338,892 8,016,590
Selling, general and administrative 4,907,652 4,169,437 8,818,485 7,533,927
Total operating expenses 10,019,750 8,546,270 19,157,377 15,550,517
Loss from operations (9,215,558) (8,456,431) (17,794,601) (15,460,678)
Other income (expense):        
Interest income 5,019 1,962 11,812 3,459
Interest expense (914,070) (465,268) (1,857,908) (828,350)
Change in fair value of financial instruments (92,332) 0 300,151 0
Loss on extinguishment of debt 0 (1,372,266) (2,610,196) (1,372,266)
Other, net (5,293) (8,348) (12,045) 16,465
Total other expense, net (1,006,676) (1,843,920) (4,168,186) (2,180,692)
Net loss attributable to common stockholders $ (10,222,234) $ (10,300,351) $ (21,962,787) $ (17,641,370)
Loss per common share (basic and diluted) $ (0.07) $ (0.09) $ (0.15) $ (0.15)
Weighted average shares outstanding (basic and diluted) 150,019,939 118,260,288 147,416,111 116,024,366